Group 1 - The company announced the acquisition of a 12% stake in Guangxi Fusion Bioenergy Technology Co., Ltd. for RMB 24 million, with the transaction expected to be completed by November 26, 2025 [1] - Guangxi Fusion primarily engages in the processing and sales of industrial oils, biodiesel, and bio-plasticizers, with key products including first-generation biodiesel (UCOM) and marine biodiesel (B24) [1] - The target company is investing in a biodiesel production facility in Nanning, China, with an annual production capacity of approximately 200,000 tons, and the first phase of construction is scheduled for completion by November 2025 [1] Group 2 - The board believes that the acquisition aligns with the company's development strategy and is expected to enhance its market share, competitiveness, and brand image in China [2] - This move represents an opportunity to expand the company's biodiesel business portfolio and is anticipated to positively contribute to the prospects of both the target company and the biodiesel industry [2] Group 3 - Global demand for biodiesel and sustainable aviation fuel (SAF) is expected to rise due to supportive global policy frameworks, including the EU's goal to reduce transport-related greenhouse gas emissions by 90% by 2050 [1] - Favorable policy developments in China, such as the removal of export tax rebates on waste cooking oil (UCO), which is a primary raw material for biodiesel and SAF, are encouraging domestic processing and promoting growth in the Chinese biofuel industry [1]
创业集团控股附属拟2400万元收购广西融合生物能源科技12%股权